← Back to Discover
Abingworth LLP
Period ended Dec 31, 2022 · Latest filing Feb 10, 2023
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Dec 31, 2022: $306,916,946
More quarters will appear as history becomes available.
Top holdings
Top 10 at Dec 31, 2022. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- VAXCYTE INC · COM · 92243G108 · shares: $96,813,783
- VERONA PHARMA PLC · SPONSORED ADS · 925050106 · shares: $64,214,475
- VERA THERAPEUTICS INC · CL A · 92337R101 · shares: $57,280,470
- HILLEVAX INC · COM · 43157M102 · shares: $30,757,871
- ADICET BIO INC · COM · 007002108 · shares: $18,911,542
- PHATHOM PHARMACEUTICALS INC · COM · 71722W107 · shares: $16,101,889
- RENEO PHARMACEUTICALS INC · COM · 75974E103 · shares: $4,832,320
- SIENTRA INC · COM · 82621J105 · shares: $3,397,386
- JASPER THERAPEUTICS INC · COM · 471871103 · shares: $2,718,594
- SOLENO THERAPEUTICS INC · COM · 834203309 · shares: $2,378,982
Reported holdings
19 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| VAXCYTE INC | COM | 92243G108 | — | 2,019,057 shares | $96,813,783 |
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | — | 2,457,500 shares | $64,214,475 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 2,960,231 shares | $57,280,470 |
| HILLEVAX INC | COM | 43157M102 | — | 1,838,486 shares | $30,757,871 |
| ADICET BIO INC | COM | 007002108 | — | 2,115,385 shares | $18,911,542 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 1,435,106 shares | $16,101,889 |
| RENEO PHARMACEUTICALS INC | COM | 75974E103 | — | 2,073,957 shares | $4,832,320 |
| SIENTRA INC | COM | 82621J105 | — | 1,673,589 shares | $3,397,386 |
| JASPER THERAPEUTICS INC | COM | 471871103 | — | 5,628,558 shares | $2,718,594 |
| SOLENO THERAPEUTICS INC | COM | 834203309 | — | 1,201,506 shares | $2,378,982 |
| NUCANA PLC | SPONSORED ADR | 67022C106 | — | 3,333,333 shares | $2,200,000 |
| EFFECTOR THERAPEUTICS INC | COM | 28202V108 | — | 4,822,114 shares | $2,063,865 |
| SPRUCE BIOSCIENCES INC | COM | 85209E109 | — | 1,792,518 shares | $1,966,392 |
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | — | 1,041,131 shares | $1,946,915 |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | — | 131,036 shares | $821,596 |
| EXICURE INC | COM NEW | 30205M200 | — | 281,636 shares | $323,881 |
| AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | — | 240,500 shares | $108,225 |
| MOLECULAR TEMPLATES INC | COM | 608550109 | — | 200,000 shares | $66,000 |
| OBSEVA SA | COM | H5861P103 | — | 87,999 shares | $12,760 |